Silvia McColl Wealth Management’s AbbVie ABBV Stock Holding History

Silvia McColl Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$728K	Sell	2,895 -18	-0.6%	-$3.87K	0.44%	55
2026 Q1	$634K	Hold	2,913	–	–	0.42%	55
2025 Q4	$666K	Hold	2,913	–	–	0.44%	52
2025 Q3	$674K	Hold	2,913	–	–	0.46%	51
2025 Q2	$541K	Hold	2,913	–	–	0.39%	62
2025 Q1	$610K	Hold	2,913	–	–	0.46%	50
2024 Q4	$518K	Sell	2,913 -207	-7%	-$38.1K	0.39%	61
2024 Q3	$616K	Hold	3,120	–	–	0.46%	51
2024 Q2	$535K	Hold	3,120	–	–	0.44%	50
2024 Q1	$527K	Buy	3,120 +66	+2%	+$11.4K	0.45%	53
2023 Q4	$473K	Hold	3,054	–	–	0.43%	57
2023 Q3	$455K	Hold	3,054	–	–	0.46%	54
2023 Q2	$411K	Hold	3,054	–	–	0.38%	61
2023 Q1	$487K	Sell	3,054 -99	-3%	-$15.1K	0.48%	51
2022 Q4	$510K	Buy	+3,153	New	+$483K	0.5%	50

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Silvia McColl Wealth Management's ABBV Position: Q2 2026 in Review

Silvia McColl Wealth Management reduced its AbbVie (ABBV) stake by 0.62% in Q2 2026, selling an estimated $3.87K and leaving 2,895 shares worth $728K. The position accounts for 0.44% of the portfolio, ranked #55.

Silvia McColl Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Silvia McColl Wealth Management held 2,895 shares of AbbVie worth $728K as of Q2 2026.
Silvia McColl Wealth Management sold 18 AbbVie shares in Q2 2026, an estimated $3.87K.
AbbVie made up 0.44% of Silvia McColl Wealth Management's portfolio in Q2 2026, its #55 holding.
Silvia McColl Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Silvia McColl Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.